Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet

ISME Journal

Volumn 8, Issue 12, 2014, Pages 2380-2396

  Walker, Alesia ^a   Pfitzner, Barbara ^a   Neschen, Susanne ^a   Kahle, Melanie ^a   Harir, Mourad ^a   Lucio, Marianna ^a   Moritz, Franco ^a   Tziotis, Dimitrios ^a   Witting, Michael ^a   Rothballer, Michael ^a   Engel, Marion ^a   Schmid, Michael ^a   Endesfelder, David ^a   Klingenspor, Martin ^b   Rattei, Thomas ^c   Castell, Wolfgang Zu ^a   De Angelis, Martin Hrabé ^a   Hartmann, Anton ^a   Schmitt Kopplin, Philippe ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

16S rRNA amplicon pyrosequencing; Bile acids; Gut microbiome; Mass spectrometry; Metabolomics; Obesity

Indexed keywords

BACTERIA (MICROORGANISMS); DEFERRIBACTERES; FIRMICUTES; MUS; PROTEOBACTERIA;

BILE ACID;

ANIMAL; BACTERIUM; C57BL MOUSE; CECUM; GASTROINTESTINAL TRACT; GENETICS; ISOLATION AND PURIFICATION; LIPID DIET; LIVER; MALE; METABOLISM; METABOLOME; METABOLOMICS; MICROBIOLOGY; MICROFLORA; OBESITY; TANDEM MASS SPECTROMETRY;

ANIMALS; BACTERIA; BILE ACIDS AND SALTS; CECUM; DIET, HIGH-FAT; GASTROINTESTINAL TRACT; LIVER; MALE; METABOLOME; METABOLOMICS; MICE, INBRED C57BL; MICROBIOTA; OBESITY; TANDEM MASS SPECTROMETRY;

EID: 84908385754     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2014.79     Document Type: Article

References (105)

1. Antunes LCM, Han J, Ferreira RBR, Lolić P, Borchers CH, Finlay BB. (2011). Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 55: 1494-1503.
2. Barker M, Rayens W. (2003). Partial least squares for discrimination. J Chemometrics 17: 166-173.
3. Baur P, Martin F-P, Gruber L, Bosco N, Brahmbhatt V, Collino S et al. (2011). Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNFDARE/WT mouse model. J Proteome Res 10: 5523-5535.
4. Benjamini Y, Hochberg Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 289: 300-1188.
5. Booth AN, Masri MS, Robbins DJ, Emerson OH, Jones FT, DeEds F. (1960). Urinary phenolic acid metabolites of tyrosine. J Biol Chem 235: 2649-2652.
6. Bylesjö M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J. (2006). OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemometrics 20: 341-351.
7. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101: 15718-15723.
8. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. (2007). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104: 979-984.
9. Caballero B. (2007). The global epidemic of obesity: An overview. Epidemiol Rev 29: 1-5.
10. Calvani R, Miccheli A, Capuani G, Miccheli AT, Puccetti C, Delfini M et al. (2010). Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes 34: 1095-1098.
11. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
12. Capasso R, Izzo AA. (2008). Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. J Neuroendocrinol 20: 39-46.
13. Choi SW, Lee SK, Kim EO, Oh JH, Yoon KS, Parris N et al. (2007). Antioxidant and antimelanogenic activities of polyamine conjugates from corn bran and related hydroxycinnamic acids. J Agric Food Chem 55: 3920-3925.
14. Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin F-P et al. (2008). Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 4: 219.
15. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ et al. (2009). The ribosomal database project: Improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37: D141-D145.
16. Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G et al. (2014). High-fat diet alters gut microbiota physiology in mice. ISME J 8: 295-308.
17. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al. (2013). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-563.
18. Dixon P. (2003). VEGAN, a package of R functions for community ecology. J Veg Sci 14: 927-930.
19. Dray S, Dufour AB. (2007). The ade4 package: Implementing the duality diagram for ecologists. J Stat Softw 22: 1-20.
20. Duggan GE, Hittel DS, Hughey CC, Weljie A, Vogel HJ, Shearer J. (2011a). Differentiating short-and long-term effects of diet in the obese mouse using 1H-nuclear magnetic resonance metabolomics. Diabetes Obes Metab 13: 859-862.
21. Duggan GE, Hittel DS, Sensen CW, Weljie AM, Vogel HJ, Shearer J. (2011b). Metabolomic response to exercise training in lean and diet-induced obese mice. J Appl Physiol (Bethesda, MD: 1985) 110: 1311-1318.
22. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A et al. (2006). Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103: 12511-12516.
23. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194-2200.
24. Eisinger K, Liebisch G, Schmitz G, Aslanidis C, Krautbauer S, Buechler C. (2014). Lipidomic analysis of serum from high fat diet induced obese mice. Int J Mol Sci 15: 2991-3002.
25. Fearnside JF, Dumas M-E, Rothwell AR, Wilder SP, Cloarec O, Toye A et al. (2008). Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS One 3: e1668.
26. Federico L, Ren H, Mueller Pa WuT, Liu S, Popovic J et al. (2012). Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice. Mol Endocrinol (Baltimore, MD) 26: 786-797.
27. Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH. (2011). Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol 4: 22-30.
28. Fox JG, Yan LL, Dewhirst FE, Paster BJ, Shames B, Murphy JC et al. (1995). Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 33: 445-454.
29. Gauffin Cano P, Santacruz A, Moya Á, Sanz Y. (2012). Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One 7: e41079.
30. Geurts L, Lazarevic V, Derrien M, Everard A, Van Roye M, Knauf C et al. (2011). Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: Impact on apelin regulation in adipose tissue. Front Microbiol 2: 149.
31. Hanhineva K, Barri T, Kolehmainen M, Pekkinen J, Pihlajamäki J, Vesterbacka A et al. (2013). Comparative nontargeted profiling of metabolic changes in tissues and biofluids in high-fat diet-fed Ossabaw pig. J Proteome Res 12: 3980-3992.
32. Hanson RF, Szczepanik-VanLeeuwen P, Williams GC, Grabowski G, Sharp HL. (1979). Defects of bile acid synthesis in Zellweger's syndrome. Science 203: 1107-1108.
33. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY et al. (2009). High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137: 1716-1724.
34. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J et al. (2009). Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One 4: e6386.
35. Jung JY, Kim IY, Kim YN, Kim JS, Shin JH, Jang ZH et al. (2012). 1H NMR-based metabolite profiling of dietinduced obesity in amouse mode. BMB Rep 45: 419-424.
36. Juretschko S, Timmermann G, Schmid M, Schleifer K-H, Pommerening-Röser A, Koops H-P et al. (1998). Combined molecular and conventional analyses of nitrifying bacterium diversity in activated sludge: Nitrosococcus mobilis and Nitrospira-like bacteria as dominant populations. Appl Environ Microbiol 64: 3042-3051.
37. Kahn BB, Flier JS. (2000). Obesity and insulin resistance. J Clin Invest 106: 473-481.
38. Kim EO, Min KJ, Kwon TK, Um BH, Moreau RA, Choi SW. (2012a). Anti-inflammatory activity of hydroxycinnamic acid derivatives isolated from corn bran in lipopolysaccharide-stimulated Raw 264.7 macrophages. Food Chem Toxicol 50: 1309-1316.
39. Kim HJ, Kim JH, Noh S, Hur HJ, Sung MJ, Hwang JT et al. (2011). Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J Proteome Res 10: 722-731.
40. Kim JY, Park JY, KimOY, HamBM, KimH-J, Kwon DYet al. (2010). Metabolic profiling of plasma in overweight/ obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res 9: 4368-4375.
41. Kim K-A, Gu W, Lee I-A, Joh E-H, Kim D-H. (2012b). High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7: e47713.
42. Kim S-H, Yang S-O, Kim H-S, Kim Y, Park T, Choi H-K. (2009). 1H-nuclear magnetic resonance spectroscopybased metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal Bioanal Chem 395: 1117-1124.
43. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG et al. (1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivatordependent receptor ligand assay. Mol Endocrinol (Baltimore, MD) 11: 779-791.
44. Lane D. (1991). 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M (eds) Nucleic Acid Techniques in Bacterial Systematics, 1st edn. Wiley: New York, pp 115-175.
45. Lawson AM, Madigan MJ, Shortland D, Clayton PT. (1986). Rapid diagnosis of Zellweger syndrome and infantile Refsum's disease by fast atom bombardment-mass spectrometry of urine bile salts. Clinica Chimica Acta 161: 221-231.
46. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. (2009). Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89: 147-191.
47. Ley RE, Bäckhed F, Turnbaugh P, Lozupone Ca, Knight RD, Gordon JI. (2005). Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102: 11070-11075.
48. Li H, Xie Z, Lin J, Song H, Wang Q, Wang K et al. (2008). Transcriptomic and metabonomic profiling of obesityprone and obesity-resistant rats under high fat diet. J Proteome Res 7: 4775-4783.
49. Li LO, Hu YF, Wang L, Mitchell M, Berger A, Coleman RA. (2010a). Early hepatic insulin resistance in mice: A metabolomics analysis. Mol Endocrinol (Baltimore, MD) 24: 657-666.
50. Li T, Francl JM, Boehme S, Ochoa A, Zhang Y, Klaassen CD et al. (2012). Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem 287: 1861-1873.
51. Li T, Owsley E, Matozel M, Hsu P, Novak CM, Chiang JYL. (2010b). Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology (Baltimore, MD) 52: 678-690.
52. Libert R, Hermans D, Draye JP, Van Hoof F, Sokal E, de Hoffmann E. (1991). Bile acids and conjugates identified in metabolic disorders by fast atom bombardment and tandem mass spectrometry. Clin Chem 37: 2102-2110.
53. Lin H-M, Helsby NA, Rowan DD, Ferguson LR. (2011). Using metabolomic analysis to understand inflammatory bowel diseases. Inflammatory Bowel Diseases 17: 1021-1029.
54. Lucio M, Fekete A, Weigert C, Wägele B, Zhao X, Chen J et al. (2010). Insulin sensitivity is reflected by characteristic metabolic fingerprints-a fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 5: e13317.
55. Ludwig W, Strunk O, Westram R, Richter L, Meier H, Yadhukumar et al. (2004). ARB: A software environment for sequence data. Nucleic Acids Res 32: 1363-1371.
56. Martin F-PJ, Dumas M-E, Wang Y, Legido-Quigley C, Yap IKS, Tang H et al. (2007). A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 3: 112.
57. Matsumoto M, Kibe R, Ooga T, Aiba Y, Kurihara S, Sawaki E et al. (2012). Impact of intestinal microbiota on intestinal luminal metabolome. Sci Rep 2: 233.
58. Mekada K, Abe K, Murakami A, Nakamura S, Nakata H, Moriwaki K et al. (2009). Genetic differences among C57BL/6 substrains. Exp Anim 58: 141-149.
59. Miyamoto Y, Itoh K. (2000). Bacteroides acidifaciens sp, nov., isolated from the caecum of mice. Int J Syst Evol Microbiol 50: 145-148.
60. Montgomery MK, Hallahan NL, Brown SH, Liu M, Mitchell TW, Cooney GJ et al. (2013). Mouse straindependent variation in obesity and glucose homeostasis in response to high-fat feeding. Diabetologia 56: 1129-1139.
61. Moreau R, Nuñez A, Singh V. (2001). Diferuloylputrescine and p-coumaroyl-feruloylputrescine, abundant polyamine conjugates in lipid extracts of maize kernels. Lipids 36: 839-844.
62. Narushima S, Itoha K, Miyamoto Y, Park S-H, Nagata K, Kuruma K et al. (2006). Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 41: 835-843.
63. Neish AS. (2009). Microbes in gastrointestinal health and disease. Gastroenterology 136: 65-80.
64. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF et al. (2009). A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326.
65. Nicholson A, Reifsnyder PC, Malcolm RD, Lucas CA, MacGregor GR, Zhang W et al. (2010). Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene. Obesity 18: 1902-1905.
66. Nicholson JK, Lindon JC, Holmes E. (1999). 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189.
67. Nobusue H, Kondo D, Yamamoto M, Kano K. (2010). Effects of lysophosphatidic acid on the in vitro proliferation and differentiation of a novel porcine preadipocyte cell line. Comp Biochem Physiol B Biochem Mol Biol 157: 401-407.
68. Oberbach A, Bluher M, Wirth H, Till H, Kovacs P, Kullnick Y et al. (2011). Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 10: 4769-4788.
69. Pruesse E, Peplies J, Glöckner FO. (2012). SINA: Accurate high-throughput multiple sequence alignment of ribosomal RNA genes. Bioinformatics 28: 1823-1829.
70. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P et al. (2013). The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res 41: D590-D596.
71. Ramette A. (2007). Multivariate analyses in microbial ecology. FEMS Microbiol Ecol 62: 142-160.
72. Ravussin Y, Koren O, Spor A, LeDuc C, Gutman R, Stombaugh J et al. (2012). Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity 20: 738-747.
73. Ridlon JM, Kang D-J, Hylemon PB. (2006). Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47: 241-259.
74. Robertson BR, O'Rourke JL, Neilan BA, Vandamme P, On SLW, Fox JG et al. (2005). Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. Int J Syst Evol Microbiol 55: 1199-1204.
75. Schloss PD, Gevers D, Westcott SL. (2011). Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 6: e27310.
76. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB et al. (2009). Introducing mothur: opensource, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75: 7537-7541.
77. Schäfer N, Yu Z, Wagener A, Millrose M, Reissmann M, Bortfeldt R et al. (2014). Changes in metabolite profiles caused by genetically determined obesity in mice. Metabolomics 10: 461-472.
78. SerinoM, Luche E, Gres S, Baylac A, Bergé M, Cenac C et al. (2012). Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61: 543-553.
79. Seyfried F, Li JV, Miras AD, Cluny NL, Lannoo M, Fenske WK et al. (2013). Urinary phenotyping indicates weight loss-independent metabolic effects of Roux-en-Y gastric bypass in mice. J Proteome Res 12: 1245-1253.
80. Shearer J, Duggan G, Weljie A, Hittel DS, Wasserman DH, Vogel HJ. (2008). Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse. Diabetes Obes Metab 10: 950-958.
81. Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H et al. (2008). Enterolactone is differently associated with estrogen receptor beta-negative and-positive breast cancer in a Swedish nested casecontrol study. Cancer Epidemiol Biomarkers Prev 17: 3241-3251.
82. Spor A, Koren O, Ley R. (2011). Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9: 279-290.
83. Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW. (2006). Peroxisome biogenesis disorders. Biochim Biophys Acta 1763: 1733-1748.
84. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE et al. (2011). Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 108: 4523-4530.
85. Tien Poll-The B, Skjeldal O, Stokke O, Poulos A, Demaugre F, Saudubray J-M. (1989). Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders. Hum Genet 81: 175-181.
86. Timmers R, Rothballer M, Strik DBTB, Engel M, Schulz S, Schloter M et al. (2012). Microbial community structure elucidates performance of Glyceria maxima plant microbial fuel cell. Appl Microbiol Biotechnol 94: 537-548.
87. Tiribelli C, Ostrow JD. (2005). Intestinal flora and bilirubin. J Hepatol 42: 170-172.
88. Tominaga S, Nishi K, Nishimoto S, Akiyama K, Yamauchi S, Sugahara T. (2012). (-)-Secoisolariciresinol attenuates high-fat diet-induced obesity in C57BL/6 mice. Food Funct 3: 76-82.
89. Toye AA, Lippiat JD, Proks P, Shimomura K, Bentley L, Hugill A et al. (2005). A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48: 675-686.
90. Trygg J. (2002). O2-PLS for qualitative and quantitative analysis in multivariate calibration. J Chemometrics 16: 283-293.
91. Trygg J, Wold S. (2002). Orthogonal projections to latent structures (O-PLS). J Chemometrics 16: 119-128.
92. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al. (2009). A core gut microbiome in obese and lean twins. Nature 457: 480-484.
93. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1131.
94. Tziotis D, Hertkorn N, Schmitt-Kopplin P. (2011). Kendrick-analogous network visualisation of ion cyclotron resonance Fourier transform mass spectra: Improved options for the assignment of elemental compositions and the classification of organic molecular complexity. Eur J Mass Spectrom 17: 415-421.
95. Waldram A, Holmes E,Wang Y, Rantalainen M, Wilson ID, Tuohy KM et al. (2009). Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 8: 2361-2375.
96. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E et al. (2011). Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem 286: 26913-26920.
97. Watanabe M, Houten SM, Mataki C, Christoffolete Ma, Kim BW, Sato H et al. (2006). Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484-489.
98. Williams R, Lenz EM, Wilson AJ, Granger J, Wilson ID, Major H et al. (2006). A multi-analytical platform approach to the metabonomic analysis of plasma from normal and zucker (fa/fa) obese rats. Mol BioSyst 2: 174-183.
99. Won E-Y, Yoon M-K, Kim S-W, Jung Y, Bae H-W, Lee D et al. (2013). Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One 8: e75998.
100. Woting A, Clavel T, Loh G, Blaut M. (2010). Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol Ecol 72: 507-514.
101. Xie B, Waters MJ, Schirra HJ. (2012). Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol 2012: 805683.
102. Xie Z, Li H, Wang K, Lin J, Wang Q, Zhao G et al. (2010). Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat. Metabolism 59: 554-560.
103. Xu J, Liu C, Cai S, Dong J, Li X, Feng J et al. (2013). Metabolomic profilings of urine and serum from high fat-fed rats via 1H NMR spectroscopy and pattern recognition. Appl Biochem Biotechnol 169: 1250-1261.
104. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W et al. (2010). Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4: 232-241.
105. Zhao LC, Zhang XD, Liao SX, Gao HC, Wang HY, Lin DH. (2010). A metabonomic comparison of urinary changes in Zucker and GK rats. J Biomed Biotechnol 2010: 431894.